Drug Patent Expirations for Sep 7, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

SYMLIN (pramlintide acetate)
Astrazeneca Ab
Patent number: 6,114,304
Expiration Date: Sep 5, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial


This post was originally published on this site
Comments are closed.